Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
P59046
UPID:
NAL12_HUMAN
Alternative names:
Monarch-1; PYRIN-containing APAF1-like protein 7; Regulated by nitric oxide
Alternative UPACC:
P59046; A8MTQ2; B3KTE7; Q8NEU4; Q9BY26
Background:
NACHT, LRR, and PYD domains-containing protein 12, also known as Monarch-1, PYRIN-containing APAF1-like protein 7, and Regulated by nitric oxide, plays a pivotal role in the immune system. It mitigates inflammation by inhibiting NF-kappa-B and ERK activation pathways, regulates NOD2 degradation, promotes bacterial tolerance, and modulates immune response against RNA viruses.
Therapeutic significance:
Linked to Familial cold autoinflammatory syndrome 2, a rare disease triggered by cold, understanding the role of this protein could open doors to potential therapeutic strategies.